Learnings From a Knowledge Mobilization Strategy to Integrate a Deprescribing Educational Curriculum Into Health Professional Programmes

Tiphaine Pierson has received research support from the Canadian Medication Appropriateness and Deprescribing Network, a health organization that receives funding from Health Canada, Accelerating Clinical Trials Canada and the Canadian Institute of Health Research. Camille Gagnon is assistant director of the Canadian Medication Appropriateness and Deprescribing Network, a health organization that receives funding from Health Canada, the Canadian Institutes of Health Research and Accelerated Clinical Trials Canada. Jennifer E. Isenor has received research funding from the Dalhousie Pharmacy Endowment Fund for deprescribing-related research and is a member of the Canadian Medication Appropriateness and Deprescribing Network's Research Committee. Louise Papillon-Ferland is a member of the Canadian Medication Appropriateness and Deprescribing Network's Health Care Provider Committee. Brenda Schuster has received research support from the Canadian Medication Appropriateness and Deprescribing Network, a health organization that receives funding from Health Canada, Accelerating Clinical Trials Canada and the Canadian Institute of Health Research. Dr. Schuster is co-chair of the Network's Health Care Provider Committee. Winnie Sun is a member of the Canadian Medication Appropriateness and Deprescribing Network's Health Care Provider Committee. Lalitha Raman-Wilms has received research support from the Canadian Medication Appropriateness and Deprescribing Network, a health organization that receives funding from Health Canada, Accelerating Clinical Trials Canada and the Canadian Institute of Health Research. Dr. Schuster is co-chair of the Network's Health Care Provider Committee. Emily G. McDonald is the scientific director of the Canadian Medication Appropriateness and Deprescribing Network, a health organization that receives funding from Health Canada, the Canadian Institute of Health Research and Accelerating Clinical Trials Canada. Dr. McDonald has received funding from CIHR and the Centre for Aging and Brain Health Innovation for her ongoing research evaluating the impact of MedSafer on prescribing practices. Data sharing not applicable to this article as no datasets were generated or analysed during the current study. Data S1: Supporting Information. Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.